Dental Partners Bidco Limited - Period Ending 2022-03-31

Dental Partners Bidco Limited - Period Ending 2022-03-31


Dental Partners Bidco Limited 10530145 false 2021-04-01 2022-03-31 2022-03-31 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.30.9574.0 true true true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false 10530145 2021-04-01 2022-03-31 10530145 2022-03-31 10530145 bus:Director3 2022-03-31 10530145 bus:OrdinaryShareClass1 2022-03-31 10530145 bus:Consolidated 2022-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2022-03-31 10530145 core:ShareCapital 2022-03-31 10530145 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 10530145 core:Non-currentFinancialInstruments 2022-03-31 10530145 core:Non-currentFinancialInstruments core:AfterOneYear 2022-03-31 10530145 bus:FRS102 2021-04-01 2022-03-31 10530145 bus:Audited 2021-04-01 2022-03-31 10530145 bus:FullAccounts 2021-04-01 2022-03-31 10530145 bus:RegisteredOffice 2021-04-01 2022-03-31 10530145 bus:Director1 2021-04-01 2022-03-31 10530145 bus:Director2 2021-04-01 2022-03-31 10530145 bus:Director3 2021-04-01 2022-03-31 10530145 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 10530145 bus:Consolidated 2021-04-01 2022-03-31 10530145 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2021-04-01 2022-03-31 10530145 core:ShareCapital 2021-04-01 2022-03-31 10530145 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2021-04-01 2022-03-31 10530145 core:Subsidiary1 2021-04-01 2022-03-31 10530145 core:Subsidiary10 2021-04-01 2022-03-31 10530145 core:Subsidiary11 2021-04-01 2022-03-31 10530145 core:Subsidiary12 2021-04-01 2022-03-31 10530145 core:Subsidiary13 2021-04-01 2022-03-31 10530145 core:Subsidiary14 2021-04-01 2022-03-31 10530145 core:Subsidiary15 2021-04-01 2022-03-31 10530145 core:Subsidiary16 2021-04-01 2022-03-31 10530145 core:Subsidiary17 2021-04-01 2022-03-31 10530145 core:Subsidiary18 2021-04-01 2022-03-31 10530145 core:Subsidiary19 2021-04-01 2022-03-31 10530145 core:Subsidiary19 countries:AllCountries 2021-04-01 2022-03-31 10530145 core:Subsidiary2 2021-04-01 2022-03-31 10530145 core:Subsidiary20 2021-04-01 2022-03-31 10530145 core:Subsidiary21 2021-04-01 2022-03-31 10530145 core:Subsidiary22 2021-04-01 2022-03-31 10530145 core:Subsidiary23 2021-04-01 2022-03-31 10530145 core:Subsidiary24 2021-04-01 2022-03-31 10530145 core:Subsidiary25 2021-04-01 2022-03-31 10530145 core:Subsidiary26 2021-04-01 2022-03-31 10530145 core:Subsidiary27 2021-04-01 2022-03-31 10530145 core:Subsidiary28 2021-04-01 2022-03-31 10530145 core:Subsidiary29 2021-04-01 2022-03-31 10530145 core:Subsidiary3 2021-04-01 2022-03-31 10530145 core:Subsidiary30 2021-04-01 2022-03-31 10530145 core:Subsidiary31 2021-04-01 2022-03-31 10530145 core:Subsidiary32 2021-04-01 2022-03-31 10530145 core:Subsidiary33 2021-04-01 2022-03-31 10530145 core:Subsidiary34 2021-04-01 2022-03-31 10530145 core:Subsidiary35 2021-04-01 2022-03-31 10530145 core:Subsidiary36 2021-04-01 2022-03-31 10530145 core:Subsidiary37 2021-04-01 2022-03-31 10530145 core:Subsidiary4 2021-04-01 2022-03-31 10530145 core:Subsidiary5 2021-04-01 2022-03-31 10530145 core:Subsidiary6 2021-04-01 2022-03-31 10530145 core:Subsidiary7 2021-04-01 2022-03-31 10530145 core:Subsidiary8 2021-04-01 2022-03-31 10530145 core:Subsidiary9 2021-04-01 2022-03-31 10530145 core:UKTax 2021-04-01 2022-03-31 10530145 countries:AllCountries 2021-04-01 2022-03-31 10530145 2021-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2021-03-31 10530145 core:ShareCapital 2021-03-31 10530145 2020-04-01 2021-03-31 10530145 2021-03-31 10530145 bus:OrdinaryShareClass1 2021-03-31 10530145 core:TaxLossesCarry-forwardsDeferredTax 2021-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2021-03-31 10530145 core:ShareCapital 2021-03-31 10530145 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 10530145 core:Non-currentFinancialInstruments 2021-03-31 10530145 core:Non-currentFinancialInstruments core:AfterOneYear 2021-03-31 10530145 core:CostValuation 2021-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2020-04-01 2021-03-31 10530145 core:ShareCapital 2020-04-01 2021-03-31 10530145 core:Subsidiary1 2020-04-01 2021-03-31 10530145 core:Subsidiary10 2020-04-01 2021-03-31 10530145 core:Subsidiary11 2020-04-01 2021-03-31 10530145 core:Subsidiary12 2020-04-01 2021-03-31 10530145 core:Subsidiary13 2020-04-01 2021-03-31 10530145 core:Subsidiary14 2020-04-01 2021-03-31 10530145 core:Subsidiary15 2020-04-01 2021-03-31 10530145 core:Subsidiary16 2020-04-01 2021-03-31 10530145 core:Subsidiary17 2020-04-01 2021-03-31 10530145 core:Subsidiary18 2020-04-01 2021-03-31 10530145 core:Subsidiary19 2020-04-01 2021-03-31 10530145 core:Subsidiary2 2020-04-01 2021-03-31 10530145 core:Subsidiary20 2020-04-01 2021-03-31 10530145 core:Subsidiary21 2020-04-01 2021-03-31 10530145 core:Subsidiary22 2020-04-01 2021-03-31 10530145 core:Subsidiary23 2020-04-01 2021-03-31 10530145 core:Subsidiary24 2020-04-01 2021-03-31 10530145 core:Subsidiary25 2020-04-01 2021-03-31 10530145 core:Subsidiary26 2020-04-01 2021-03-31 10530145 core:Subsidiary27 2020-04-01 2021-03-31 10530145 core:Subsidiary28 2020-04-01 2021-03-31 10530145 core:Subsidiary29 2020-04-01 2021-03-31 10530145 core:Subsidiary3 2020-04-01 2021-03-31 10530145 core:Subsidiary30 2020-04-01 2021-03-31 10530145 core:Subsidiary31 2020-04-01 2021-03-31 10530145 core:Subsidiary32 2020-04-01 2021-03-31 10530145 core:Subsidiary33 2020-04-01 2021-03-31 10530145 core:Subsidiary34 2020-04-01 2021-03-31 10530145 core:Subsidiary35 2020-04-01 2021-03-31 10530145 core:Subsidiary36 2020-04-01 2021-03-31 10530145 core:Subsidiary37 2020-04-01 2021-03-31 10530145 core:Subsidiary4 2020-04-01 2021-03-31 10530145 core:Subsidiary5 2020-04-01 2021-03-31 10530145 core:Subsidiary6 2020-04-01 2021-03-31 10530145 core:Subsidiary7 2020-04-01 2021-03-31 10530145 core:Subsidiary8 2020-04-01 2021-03-31 10530145 core:Subsidiary9 2020-04-01 2021-03-31 10530145 core:UKTax 2020-04-01 2021-03-31 10530145 2020-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2020-03-31 10530145 core:ShareCapital 2020-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10530145

Dental Partners Bidco Limited

Annual Report and Financial Statements

for the Year Ended 31 March 2022

 

Dental Partners Bidco Limited

Contents

Company Information

1

Directors' Report

2

Strategic Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Profit and Loss Account

8

Balance Sheet

9

Statement of Changes in Equity

10

Notes to the Financial Statements

11 to 17

 

Dental Partners Bidco Limited

Company Information

Directors

N A Lloyd

N R Osborne

Registered office

Dental Partners Support Centre
476-478 Bristol Road
Selly Oak
Birmingham
B29 6BQ

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Dental Partners Bidco Limited

Directors' Report for the Year Ended 31 March 2022

The directors present their report and the financial statements for the year ended 31 March 2022.

Directors of the company

The directors who held office during the year were as follows:

N A Lloyd

N R Osborne

C A Dube (ceased 29 April 2022)

Disclosure of information to the auditors

Each director has taken the steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

Hazlewoods LLP have expressed their willingness to continue in office.

Approved by the Board on 11 August 2022 and signed on its behalf by:


N A Lloyd
Director

 

Dental Partners Bidco Limited

Strategic Report for the Year Ended 31 March 2022

The directors present their strategic report for the year ended 31 March 2022.

Principal activity

The principal activity of the company is that of a holding company.

Fair review of the business

At 31 March 2022, the company had total assets less current liabilities of £68,270,289 (2021 - £69,220,834). The directors consider the financial position at the year end to be satisfactory.

Future developments, principal risks and uncertainties, key performance indicators, financial instruments and going concern are all disclosed in the financial statements of Dental Partners Group Limited as the ultimate parent company.

Approved by the Board on 11 August 2022 and signed on its behalf by:


N A Lloyd
Director

 

Dental Partners Bidco Limited

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report, Strategic Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards has been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

Opinion

We have audited the financial statements of Dental Partners Bidco Limited (the 'company') for the year ended 31 March 2022, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 March 2022 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors’ remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

As part of an audit in accordance with ISAs (UK), we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
• Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion.

Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
• Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the company to express an opinion on the financial statements.We are responsible for the direction, supervision and performance of the company audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.





Martin Howard (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

12 August 2022

 

Dental Partners Bidco Limited

Profit and Loss Account for the Year Ended 31 March 2022

Note

2022
 £

2021
 £

Turnover

-

-

Interest payable and similar charges

5

(9,261,985)

(8,664,984)

Loss before tax

 

(9,261,985)

(8,664,984)

Taxation

7

(315,744)

315,744

Loss for the financial year

 

(9,577,729)

(8,349,240)

The above results were derived from continuing operations.

The company has no other comprehensive income for the year.

 

Dental Partners Bidco Limited

(Registration number: 10530145)
Balance Sheet as at 31 March 2022

Note

2022
 £

2021
 £

Fixed assets

 

Investments

8

11,407,903

11,407,903

Current assets

 

Debtors

9

93,146,449

90,688,162

Creditors: Amounts falling due within one year

10

(36,284,063)

(32,875,231)

Net current assets

 

56,862,386

57,812,931

Total assets less current liabilities

 

68,270,289

69,220,834

Creditors: Amounts falling due after more than one year

10

94,689,197

86,062,013

Capital and reserves

 

Called up share capital

12

405,332

405,332

Profit and loss account

(26,824,240)

(17,246,511)

Total equity

 

(26,418,908)

(16,841,179)

Total capital, reserves and long term liabilities

 

68,270,289

69,220,834

Approved and authorised by the Board on 11 August 2022 and signed on its behalf by:
 


N A Lloyd
Director

 

Dental Partners Bidco Limited

Statement of Changes in Equity for the Year Ended 31 March 2022

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2021

405,332

(17,246,511)

(16,841,179)

Loss for the year

-

(9,577,729)

(9,577,729)

At 31 March 2022

405,332

(26,824,240)

(26,418,908)

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2020

405,332

(8,897,271)

(8,491,939)

Loss for the year

-

(8,349,240)

(8,349,240)

At 31 March 2021

405,332

(17,246,511)

(16,841,179)

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Dental Partners Support Centre
476-478 Bristol Road
Selly Oak
Birmingham
B29 6BQ

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Summary of disclosure exemptions

The company has not presented a cash flow statement on the grounds that the company is a wholly owned subsidiary and a group cash flow statement is included in the financial statements of the parent company.

Name of parent of group

These financial statements are consolidated in the financial statements of Dental Partners Group Limited.

The financial statements of Dental Partners Group Limited may be obtained from Companies House.

Group accounts not prepared

The financial statements present information about the company as an individual undertaking and not about its group. The company has not prepared group accounts as it is exempt from the requirements to do so by section 400 of the Companies Act 2006 as it is a subsidiary undertaking of Dental Partners Group Limited, a company incorporated in England and Wales, and is included in the consolidated accounts of that company.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Staff costs

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2022
 No.

2021
 No.

Directors

3

3

There are no employees within the company other than the directors.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

 

4

Directors' remuneration

The directors' remuneration for the year was borne by a fellow group undertaking.

 

5

Interest payable and similar expenses

2022
£

2021
£

Bank loan interest payable

8,527,059

8,038,507

Finance costs adjacent to interest

734,926

626,477

9,261,985

8,664,984

 

6

Auditors' remuneration

Audit fees for the year have been borne by a fellow group undertaking.

 

7

Taxation

Tax charged/(credited) in the profit and loss account

2022
 £

2021
 £

Deferred taxation

Arising from previously unrecognised tax loss, tax credit or temporary difference of prior periods

315,744

(315,744)

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2021 - higher than the standard rate of corporation tax in the UK) of 19% (2021 - 19%).

The differences are reconciled below:

2022
£

2021
£

Loss before tax

(9,261,985)

(8,664,984)

Corporation tax at standard rate

(1,759,777)

(1,646,347)

Effect of expense not deductible in determining taxable profit (tax loss)

401,524

17,355

Increase from tax losses for which no deferred tax asset was recognised

278,053

-

Deferred tax expense/(credit) from unrecognised tax loss or credit

315,744

(315,744)

Tax increase arising from group relief

1,080,200

1,628,992

Total tax charge/(credit)

315,744

(315,744)

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

Deferred tax

Deferred tax assets and liabilities

2021

Asset
£

Tax losses carry-forwards

315,744

   

There is no expiry date on timing differences, unused tax losses or tax credits.

As announced in the Chancellor’s budget on 3 March 2021, the main rate of corporation tax in the United Kingdom will increase from 19% to 25% from April 2023. This rate has been substantively enacted at the balance sheet date.

The company has tax losses available to carry forward and offset against future profits of £1,463,437 (2021 - £nil). A deferred tax asset in respect of these losses of £365,859 (2021 - £nil) has not been recognised on the grounds that there is insufficient evidence that the asset will be recoverable in the foreseeable future.

 

8

Investments

2022
£

2021
£

Investments in subsidiaries

11,407,903

11,407,903

Subsidiaries

£

Cost and carrying amount

At 1 April 2021 and at 31 March 2022

11,407,903

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2022

2021

Subsidiary undertakings

Dental Partners Holdings Limited *

England and Wales

Ordinary

100%

100%

 

     

Dental Partners Trading Limited **

England and Wales

Ordinary

100%

100%

 

     

Genesis CDA Limited ***

England and Wales

Ordinary

100%

100%

 

     

Lincoln CDA Limited **

England and Wales

Ordinary

100%

100%

 

     

Dental Partners (DISA) Limited **

England and Wales

Ordinary

100%

100%

 

     

Yorkshire And Humberside CDA Limited **

England and Wales

Ordinary

100%

100%

 

     

Taptonville House Limited **

England and Wales

Ordinary

100%

100%

 

     

Marhall Holdings Limited ***

England and Wales

Ordinary

100%

100%

 

     

Humber And Yorkshire CDA Limited **

England and Wales

Ordinary

100%

100%

 

     

HC 1287 Limited ***

England and Wales

Ordinary

100%

100%

 

     

Hurlfield Limited **

England and Wales

Ordinary

100%

100%

 

     

Newtown (No 1) Limited **

England and Wales

Ordinary

100%

100%

 

     

Dentapol Limited **

England and Wales

Ordinary

100%

100%

 

     

Kaye And Rafferty Limited **

England and Wales

Ordinary

100%

100%

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

 

     

Prime Dental Care Limited **

England and Wales

Ordinary

100%

100%

 

     

Wickersley Dental Practice Limited **

England and Wales

Ordinary

100%

100%

 

     

McDaid Dental Care Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat & Ray Holdings Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care Limited **

Ordinary

100%

100%

 

England and Wales

     

Ravat and Ray Dental Care (Chadderton) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Chorley) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Bradford) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Burnley) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Fitton Hill) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Ormskirk) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Salford) Limited **

England and Wales

Ordinary

100%

100%

 

     

Ravat and Ray Dental Care (Wigan) Limited **

England and Wales

Ordinary

100%

100%

 

     

Highfield Dental Practice Limited **

England and Wales

Ordinary

100%

100%

 

     

Greater Manchester Dental Alliance Limited **

England and Wales

Ordinary

100%

100%

 

     

Greater Manchester Dental Alliance (NE) Limited **

England and Wales

Ordinary

100%

100%

 

     

Dental Sense Limited **

England and Wales

Ordinary

100%

100%

 

     

Dental Partners Morley Limited **

England and Wales

Ordinary

100%

100%

 

     

Dental Partners Kiveton Limited **

England and Wales

Ordinary

100%

100%

 

     

Dental Partners Conisborough Limited **

England and Wales

Ordinary

100%

100%

 

     

DA Clinics Limited **

England and Wales

Ordinary

100%

100%

 

     

Selby Dental Care Ltd **

England and Wales

Ordinary

100%

0%

 

     

Number 9 Dental Care Limited **

England and Wales

Ordinary

100%

0%

 

     

* - The principal activity is as a holding company.
** - The principal activity is the provision of dental services.
*** - The principal activity is as a dormant company.

Dental Partners Holdings Limited is held directly. All other companies are held indirectly.

 

9

Debtors

Note

2022
 £

2021
 £

Amounts owed by group undertakings

 

93,146,449

90,372,418

Deferred tax assets

7

-

315,744

   

93,146,449

90,688,162

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2022

 

10

Creditors

2022
 £

2021
 £

Due within one year

Amounts due to group undertakings

36,274,063

32,875,231

Accrued expenses

10,000

-

36,284,063

32,875,231

Due after one year

Loans and borrowings

94,689,197

86,062,013

 

11

Loans and borrowings

2022
£

2021
£

Non-current loans and borrowings

Bank borrowings

94,689,197

86,062,013

Total bank loans outstanding of £94,689,197 (2021 - £86,062,013) include interest accrued of £3,657,120 (2021 - £4,512,505) and are stated after deducting £1,661,080 (2021 - £2,137,492) of costs associated with the raising of this finance which are being released to the Profit and Loss account over the term of the debt. The loans are repayable in a lump sum on 11 April 2024. Interest is levied at a rate of 7.5%-12% over SONIA per annum, subject to the group’s compliance with banking covenants.

 

12

Share capital

Allotted, called up and fully paid shares

 

2022

2021

 

No.

£

No.

£

Ordinary shares of £1 each

405,332

405,332

405,332

405,332

         
 

13

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company and key management personnel compensation is disclosed in note 4 to the financial statements.

 

14

Parent and ultimate parent undertaking

The company's immediate parent is Dental Partners Finco Limited, incorporated in England and Wales.

 The ultimate parent is Dental Partners Group Limited, incorporated in England and Wales.

 Up to 29 April 2022, the ultimate controlling party was August Equity LLP, an entity registered in England and Wales, which is considered to have no single controlling party.

Since 29 April 2022, the Company is controlled by CapVest Equity Partners IV SCSp and CV Strategic Opportunities 8 SCSp, which are companies registered in Luxembourg, and are considered to have no single controlling party.